Literature DB >> 9383411

Predicting ligand binding to proteins by affinity fingerprinting.

L M Kauvar1, D L Higgins, H O Villar, J R Sportsman, A Engqvist-Goldstein, R Bukar, K E Bauer, H Dilley, D M Rocke.   

Abstract

BACKGROUND: There are many ways to represent a molecule's properties, including atomic-connectivity drawings, NMR spectra, and molecular orbital models. Prior methods for predicting the biological activity of compounds have largely depended on these physical representations. Measuring a compound's binding potency against a small reference panel of diverse proteins defines a very different representation of the molecule, which we call an affinity fingerprint. Statistical analysis of such fingerprints provides new insights into aspects of binding interactions that are shared among a wide variety of proteins. These analyses facilitate prediction of the binding properties of these compounds assayed against new proteins.
RESULTS: Affinity fingerprints are reported for 122 structurally-diverse compounds using a reference panel of eight proteins that collectively are able to generate unique fingerprints for about 75% of the small organic compounds tested. Application of multivariate regression techniques to this database enables the creation of computational surrogates to represent new proteins that are surprisingly effective at predicting binding potencies. We illustrate this for two enzymes with no previously recognizable similarity to each other or to any of the reference proteins. Fitting of analogous computational surrogates to four other proteins confirms the generality of the method; when applied to a fingerprinted library of 5000 compounds, several sub-micromolar hits were correctly predicted.
CONCLUSIONS: An affinity fingerprint database, which provides a rich source of data defining operational similarities among proteins, can be used to test theories of cryptic homology unexpected from current understanding of protein structure. Practical applications to drug design include efficient pre-screening of large numbers of compounds against target proteins using fingerprint similarities, supplemented by a small number of empirical measurements, to select promising compounds for further study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9383411     DOI: 10.1016/1074-5521(95)90283-x

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  28 in total

1.  Statistical relationships among docking scores for different protein binding sites.

Authors:  R T Koehler; H O Villar
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

Review 2.  Redox platforms in cancer drug discovery and development.

Authors:  Kenneth D Tew; Danyelle M Townsend
Journal:  Curr Opin Chem Biol       Date:  2010-11-11       Impact factor: 8.822

3.  Biological spectra analysis: Linking biological activity profiles to molecular structure.

Authors:  Anton F Fliri; William T Loging; Peter F Thadeio; Robert A Volkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

Review 4.  Chemogenomic approaches to rational drug design.

Authors:  D Rognan
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

5.  Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model.

Authors:  C W Murray; T R Auton; M D Eldridge
Journal:  J Comput Aided Mol Des       Date:  1998-09       Impact factor: 3.686

6.  Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling.

Authors:  Mathias J Wawer; Kejie Li; Sigrun M Gustafsdottir; Vebjorn Ljosa; Nicole E Bodycombe; Melissa A Marton; Katherine L Sokolnicki; Mark-Anthony Bray; Melissa M Kemp; Ellen Winchester; Bradley Taylor; George B Grant; C Suk-Yee Hon; Jeremy R Duvall; J Anthony Wilson; Joshua A Bittker; Vlado Dančík; Rajiv Narayan; Aravind Subramanian; Wendy Winckler; Todd R Golub; Anne E Carpenter; Alykhan F Shamji; Stuart L Schreiber; Paul A Clemons
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 7.  Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.

Authors:  Cory M Johannessen; Paul A Clemons; Bridget K Wagner
Journal:  Trends Genet       Date:  2014-12-12       Impact factor: 11.639

8.  Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses.

Authors:  Vlado Dančík; Hyman Carrel; Nicole E Bodycombe; Kathleen Petri Seiler; Dina Fomina-Yadlin; Stefan T Kubicek; Kimberly Hartwell; Alykhan F Shamji; Bridget K Wagner; Paul A Clemons
Journal:  J Biomol Screen       Date:  2014-01-24

9.  Relating the shape of protein binding sites to binding affinity profiles: is there an association?

Authors:  Zoltán Simon; Margit Vigh-Smeller; Agnes Peragovics; Gábor Csukly; Gergely Zahoránszky-Kohalmi; Anna A Rauscher; Balázs Jelinek; Péter Hári; István Bitter; András Málnási-Csizmadia; Pál Czobor
Journal:  BMC Struct Biol       Date:  2010-10-05

10.  A similarity search using molecular topological graphs.

Authors:  Yoshifumi Fukunishi; Haruki Nakamura
Journal:  J Biomed Biotechnol       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.